Linzess (Linaclotide) (145 Microgram, Capsules)


Indications and Reactions:

Role Indications Reactions
Primary
Constipation 65.6%
Irritable Bowel Syndrome 31.6%
Abdominal Pain 0.9%
Gastrointestinal Disorder 0.5%
Gastrointestinal Pain 0.5%
Nausea 0.5%
Spinal Cord Injury 0.5%
Diarrhoea 38.7%
Drug Ineffective 18.6%
Flatulence 8.3%
Pruritus 3.4%
Abdominal Pain 2.9%
Faecal Incontinence 2.9%
Off Label Use 2.9%
Abdominal Pain Upper 2.5%
Headache 2.5%
Nausea 2.5%
Constipation 2.0%
Rash 2.0%
Dizziness 1.5%
Dyspepsia 1.5%
Faeces Hard 1.5%
Tremor 1.5%
Vomiting 1.5%
Weight Increased 1.5%
Abdominal Distension 1.0%
Accidental Exposure To Product 1.0%
Secondary
Irritable Bowel Syndrome 46.7%
Constipation 43.3%
Abdominal Pain 6.7%
Depression 3.3%
Diarrhoea 43.8%
Drug Ineffective 12.5%
Headache 12.5%
Flatulence 6.3%
Nausea 6.3%
Off Label Use 6.3%
Panic Attack 6.3%
Unevaluable Event 6.3%
Concomitant
Constipation 100.0%
Unevaluable Event 100.0%

Drug Data